TreeWAS – Variant ID: rs6047800

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44.3 Skin of other and unspecified parts of face	1.000	0.000	0.000
C44 Other malignant neoplasms of skin	1.000	0.000	0.000
C44.5 Skin of trunk	1.000	0.000	0.000
C44.7 Skin of lower limb, including hip	0.996	0.004	0.000
C44.6 Skin of upper limb, including shoulder	0.996	0.004	0.000
C44.0 Skin of lip	0.992	0.008	0.000
C44.4 Skin of scalp and neck	0.971	0.029	0.000
C44.2 Skin of ear and external auricular canal	0.958	0.042	0.000
C44.1 Skin of eyelid, including canthus	0.817	0.183	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.815	0.185	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.775	0.225	0.000
C43 Malignant melanoma of skin	0.730	0.270	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.721	0.279	0.000
C44.8 Overlapping lesion of skin	0.717	0.283	0.000
C43.5 Malignant melanoma of trunk	0.641	0.359	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.540	0.460	0.000
C43.8 Overlapping malignant melanoma of skin	0.523	0.477	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.523	0.477	0.000
C43.0 Malignant melanoma of lip	0.523	0.477	0.000
C43.4 Malignant melanoma of scalp and neck	0.458	0.542	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.424	0.576	0.000
C43.9 Malignant melanoma of skin, unspecified	0.406	0.594	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.163	0.837	0.000
Z45.8 Adjustment and management of other implanted devices	0.000	0.908	0.092
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.926	0.074
T39.1 4-Aminophenol derivatives	0.000	0.926	0.074
T39.0 Salicylates	0.000	0.928	0.072
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.938	0.062
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.938	0.062
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.940	0.060
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.940	0.060
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.940	0.060
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.944	0.056
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.946	0.054
T39.4 Antirheumatics, not elsewhere classified	0.000	0.946	0.054
T39.2 Pyrazolone derivatives	0.000	0.946	0.054
T43.2 Other and unspecified antidepressants	0.000	0.948	0.052
T36 Poisoning by systemic antibiotics	0.000	0.949	0.051
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.950	0.050
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.951	0.049
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.953	0.047
T43.6 Psychostimulants with abuse potential	0.000	0.953	0.047
T43.9 Psychotropic drug, unspecified	0.000	0.955	0.045
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.955	0.045
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.955	0.045
T36.0 Penicillins	0.000	0.955	0.044
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.956	0.044
Z45 Adjustment and management of implanted device	0.000	0.956	0.044
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.957	0.043
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.957	0.043
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.957	0.043
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.957	0.043
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.957	0.042
Z45.1 Adjustment and management of infusion pump	0.000	0.958	0.042
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.958	0.042
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.959	0.041
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.960	0.040
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.962	0.038
T40.4 Other synthetic narcotics	0.000	0.962	0.038
T36.9 Systemic antibiotic, unspecified	0.000	0.963	0.037
T36.8 Other systemic antibiotics	0.000	0.963	0.037
T36.7 Antifungal antibiotics, systemically used	0.000	0.963	0.037
T36.6 Rifamycins	0.000	0.963	0.037
T36.5 Aminoglycosides	0.000	0.963	0.037
T36.4 Tetracyclines	0.000	0.963	0.037
T36.3 Macrolides	0.000	0.963	0.037
T36.2 Chloramphenicol group	0.000	0.963	0.037
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.963	0.037
T38.9 Other and unspecified hormone antagonists	0.000	0.964	0.036
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.964	0.036
T38.7 Androgens and anabolic congeners	0.000	0.964	0.036
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.964	0.036
T38.5 Other oestrogens and progestogens	0.000	0.964	0.036
T38.4 Oral contraceptives	0.000	0.964	0.036
T38.2 Antithyroid drugs	0.000	0.964	0.036
T38.0 Glucocorticoids and synthetic analogues	0.000	0.964	0.036
T38.1 Thyroid hormones and substitutes	0.000	0.965	0.035
T46.1 Calcium-channel blockers	0.000	0.966	0.034
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.966	0.034
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.966	0.034
T46.7 Peripheral vasodilators	0.000	0.966	0.034
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.966	0.034
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.966	0.034
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.966	0.034
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.968	0.032
Z45.9 Adjustment and management of unspecified implanted device	0.000	0.968	0.032
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.969	0.031
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.969	0.031
T37.5 Antiviral drugs	0.000	0.969	0.031
T37.4 Anthelminthics	0.000	0.969	0.031
T37.3 Other antiprotozoal drugs	0.000	0.969	0.031
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.969	0.031
T37.1 Antimycobacterial drugs	0.000	0.969	0.031
T37.0 Sulphonamides	0.000	0.969	0.031
T41.5 Therapeutic gases	0.000	0.969	0.031
T41.4 Anaesthetic, unspecified	0.000	0.969	0.031
T41.3 Local anaesthetics	0.000	0.969	0.031
T41.2 Other and unspecified general anaesthetics	0.000	0.969	0.031
T41.1 Intravenous anaesthetics	0.000	0.969	0.031
T41.0 Inhaled anaesthetics	0.000	0.969	0.031
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.969	0.031
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.969	0.031
T48.5 Anti-common-cold drugs	0.000	0.969	0.031
T48.4 Expectorants	0.000	0.969	0.031
T48.3 Antitussives	0.000	0.969	0.031
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.969	0.031
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.969	0.031
T48.0 Oxytocic drugs	0.000	0.969	0.031
T49.9 Topical agent, unspecified	0.000	0.969	0.031
T49.8 Other topical agents	0.000	0.969	0.031
T49.7 Dental drugs, topically applied	0.000	0.969	0.031
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.969	0.031
T49.5 Ophthalmological drugs and preparations	0.000	0.969	0.031
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.969	0.031
T49.3 Emollients, demulcents and protectants	0.000	0.969	0.031
T49.2 Local astringents and local detergents	0.000	0.969	0.031
T49.1 Antipruritics	0.000	0.969	0.031
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.969	0.031
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.969	0.031
T40.8 Lysergide [LSD]	0.000	0.969	0.031
T40.7 Cannabis (derivatives)	0.000	0.969	0.031
T40.5 Cocaine	0.000	0.969	0.031
T40.3 Methadone	0.000	0.969	0.031
T40.1 Heroin	0.000	0.969	0.031
T40.0 Opium	0.000	0.969	0.031
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.970	0.030
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.970	0.030
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.970	0.029
T50.8 Diagnostic agents	0.000	0.970	0.029
T50.7 Analeptics and opioid receptor antagonists	0.000	0.970	0.029
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.970	0.029
T50.5 Appetite depressants	0.000	0.970	0.029
T50.4 Drugs affecting uric acid metabolism	0.000	0.970	0.029
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.970	0.029
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.970	0.029
T50.1 Loop [high-ceiling] diuretics	0.000	0.970	0.029
T50.0 Mineralocorticoids and their antagonists	0.000	0.970	0.029
Z45.3 Adjustment and management of implanted hearing device	0.000	0.972	0.028
T40.6 Other and unspecified narcotics	0.000	0.972	0.028
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.972	0.028
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.972	0.027
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.972	0.027
T47.7 Emetics	0.000	0.972	0.027
T47.6 Antidiarrhoeal drugs	0.000	0.972	0.027
T47.5 Digestants	0.000	0.972	0.027
T47.4 Other laxatives	0.000	0.972	0.027
T47.3 Saline and osmotic laxatives	0.000	0.972	0.027
T47.2 Stimulant laxatives	0.000	0.972	0.027
T47.0 Histamine H(2)-receptor antagonists	0.000	0.972	0.027
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.973	0.027
T45.0 Antiallergic and antiemetic drugs	0.000	0.977	0.023
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.978	0.022
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.978	0.022
T45.8 Other primarily systemic and haematological agents	0.000	0.978	0.022
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.978	0.022
T45.6 Fibrinolysis-affecting drugs	0.000	0.978	0.022
T45.4 Iron and its compounds	0.000	0.978	0.022
T45.3 Enzymes, not elsewhere classified	0.000	0.978	0.022
T45.5 Anticoagulants	0.000	0.979	0.020
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.979	0.020
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.980	0.020
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.980	0.020
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.980	0.020
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.980	0.020
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.980	0.020
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.980	0.020
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.980	0.020
T44.0 Anticholinesterase agents	0.000	0.980	0.020
T45.2 Vitamins, not elsewhere classified	0.000	0.980	0.020
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.981	0.019
T40.2 Other opioids	0.000	0.983	0.017
T42.0 Hydantoin derivatives	0.000	0.984	0.016
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.985	0.015
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.985	0.015
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.985	0.015
T42.3 Barbiturates	0.000	0.985	0.015
T42.2 Succinimides and oxazolidinediones	0.000	0.985	0.015
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.985	0.014
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.985	0.015
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.986	0.014
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.986	0.014
T42.1 Iminostilbenes	0.000	0.986	0.014
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.986	0.014
R22.0 Localised swelling, mass and lump, head	0.000	0.986	0.014
R22.1 Localised swelling, mass and lump, neck	0.000	0.986	0.014
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.988	0.012
T42.4 Benzodiazepines	0.000	0.989	0.011
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.010	0.990	0.000
M50.0 Cervical disk disorder with myelopathy	0.000	0.990	0.010
R22.2 Localised swelling, mass and lump, trunk	0.000	0.990	0.010
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.990	0.010
Z45.2 Adjustment and management of vascular access device	0.000	0.990	0.010
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.992	0.008
Z80.4 Family history of malignant neoplasm of genital organs	0.007	0.993	0.000
Z80.5 Family history of malignant neoplasm of urinary tract	0.007	0.993	0.000
Z80 Family history of malignant neoplasm	0.007	0.993	0.000
N81.4 Uterovaginal prolapse, unspecified	0.007	0.993	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.994	0.006
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues	0.006	0.994	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.000	0.994	0.006
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.994	0.006
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.006	0.994	0.000
Z80.3 Family history of malignant neoplasm of breast	0.006	0.994	0.000
Z80.6 Family history of leukaemia	0.006	0.994	0.000
S32.0 Fracture of lumbar vertebra	0.000	0.994	0.006
Q50.4 Embryonic cyst of Fallopian tube	0.005	0.995	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.005	0.995	0.000
G72.9 Myopathy, unspecified	0.005	0.995	0.000
O26.8 Other specified pregnancy-related conditions	0.000	0.995	0.005
S66 Injury of muscle and tendon at wrist and hand level	0.005	0.995	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.996	0.004
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.000	0.996	0.004
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs	0.004	0.996	0.000
S32.01 Fracture of lumbar vertebra (open)	0.000	0.996	0.004
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.004	0.996	0.000
Z80.8 Family history of malignant neoplasm of other organs or systems	0.004	0.996	0.000
J93.9 Pneumothorax, unspecified	0.000	0.996	0.004
Z80.9 Family history of malignant neoplasm, unspecified	0.004	0.996	0.000
O03.4 Incomplete, without complication	0.000	0.996	0.004
R13 Dysphagia	0.004	0.996	0.000
S66.8 Injury of other muscles and tendons at wrist and hand level	0.004	0.996	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.004	0.996	0.000
Q50.5 Embryonic cyst of broad ligament	0.004	0.996	0.000
G72 Other myopathies	0.004	0.996	0.000
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.003	0.996	0.000
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.003	0.996	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.003	0.997	0.000
Q50.3 Other congenital malformations of ovary	0.003	0.997	0.000
Q50.2 Congenital torsion of ovary	0.003	0.997	0.000
Q50.1 Developmental ovarian cyst	0.003	0.997	0.000
Q50.0 Congenital absence of ovary	0.003	0.997	0.000
D68.8 Other specified coagulation defects	0.000	0.997	0.003
K55.2 Angiodysplasia of colon	0.000	0.997	0.003
F17.2 Dependence syndrome	0.003	0.997	0.000
N97.9 Female infertility, unspecified	0.003	0.997	0.000
T78.3 Angioneurotic oedema	0.000	0.997	0.003
J33.0 Polyp of nasal cavity	0.000	0.997	0.003
G70.9 Myoneural disorder, unspecified	0.003	0.997	0.000
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.003	0.997	0.000
Q50-Q56 Congenital malformations of genital organs	0.003	0.997	0.000
G72.8 Other specified myopathies	0.003	0.997	0.000
G70 Myasthenia gravis and other myoneural disorders	0.003	0.997	0.000
G72.4 Inflammatory myopathy, not elsewhere classified	0.003	0.997	0.000
G72.3 Periodic paralysis	0.003	0.997	0.000
G72.2 Myopathy due to other toxic agents	0.003	0.997	0.000
G72.1 Alcoholic myopathy	0.003	0.997	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.003	0.997	0.000
F60.9 Personality disorder, unspecified	0.000	0.997	0.003
G72.0 Drug-induced myopathy	0.003	0.997	0.000
C18.7 Sigmoid colon	0.003	0.997	0.000
G70-G73 Diseases of myoneural junction and muscle	0.003	0.997	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.003	0.997	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.000	0.997	0.003
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.002	0.997	0.000
B34.9 Viral infection, unspecified	0.003	0.997	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.997	0.003
G70.0 Myasthenia gravis	0.003	0.997	0.000
T93.2 Sequelae of other fractures of lower limb	0.003	0.997	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.997	0.003
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.000	0.997	0.003
M34.1 CR(E)ST syndrome	0.000	0.997	0.003
Q55 Other congenital malformations of male genital organs	0.002	0.997	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.000	0.997	0.002
Q53 Undescended testicle	0.002	0.998	0.000
Q54 Hypospadias	0.002	0.998	0.000
G71 Primary disorders of muscles	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.000	0.998	0.002
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.002	0.998	0.000
Q51 Congenital malformations of uterus and cervix	0.002	0.998	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.002	0.998	0.000
Q52 Other congenital malformations of female genitalia	0.002	0.998	0.000
G70.8 Other specified myoneural disorders	0.002	0.998	0.000
G70.2 Congenital and developmental myasthenia	0.002	0.998	0.000
G70.1 Toxic myoneural disorders	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
L30.9 Dermatitis, unspecified	0.000	0.998	0.002
Q51.2 Other doubling of uterus	0.002	0.998	0.000
Q54.9 Hypospadias, unspecified	0.002	0.998	0.000
Q55.6 Other congenital malformations of penis	0.002	0.998	0.000
G71.3 Mitochondrial myopathy, not elsewhere classified	0.002	0.998	0.000
N03.9 Unspecified	0.002	0.998	0.000
S50.9 Superficial injury of forearm, unspecified	0.000	0.998	0.002
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.002	0.998	0.000
M34.8 Other forms of systemic sclerosis	0.000	0.998	0.002
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.000	0.998	0.002
N81.3 Complete uterovaginal prolapse	0.000	0.998	0.002
Q21.1 Atrial septal defect	0.002	0.998	0.000
Q53.1 Undescended testicle, unilateral	0.002	0.998	0.000
M34 Systemic sclerosis	0.000	0.998	0.002
H72.0 Central perforation of tympanic membrane	0.002	0.998	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
S72.40 Fracture of lower end of femur (closed)	0.002	0.998	0.000
Q55.9 Congenital malformation of male genital organ, unspecified	0.002	0.998	0.000
Q55.8 Other specified congenital malformations of male genital organs	0.002	0.998	0.000
Q55.5 Congenital absence and aplasia of penis	0.002	0.998	0.000
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate	0.002	0.998	0.000
Q55.3 Atresia of vas deferens	0.002	0.998	0.000
Q55.1 Hypoplasia of testis and scrotum	0.002	0.998	0.000
Q55.0 Absence and aplasia of testis	0.002	0.998	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.998	0.002
Q53.9 Undescended testicle, unspecified	0.002	0.998	0.000
Q53.2 Undescended testicle, bilateral	0.002	0.998	0.000
Q53.0 Ectopic testis	0.002	0.998	0.000
Q54.8 Other hypospadias	0.002	0.998	0.000
Q54.4 Congenital chordee	0.002	0.998	0.000
Q54.3 Hypospadias, perineal	0.002	0.998	0.000
Q54.2 Hypospadias, penoscrotal	0.002	0.998	0.000
Q54.1 Hypospadias, penile	0.002	0.998	0.000
Q55.2 Other congenital malformations of testis and scrotum	0.002	0.998	0.000
F60 Specific personality disorders	0.000	0.998	0.002
G71.9 Primary disorder of muscle, unspecified	0.002	0.998	0.000
G71.8 Other primary disorders of muscles	0.002	0.998	0.000
G71.2 Congenital myopathies	0.002	0.998	0.000
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
G71.1 Myotonic disorders	0.002	0.998	0.000
G71.0 Muscular dystrophy	0.002	0.998	0.000
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.002	0.998	0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.002	0.998	0.000
Q51.6 Embryonic cyst of cervix	0.002	0.998	0.000
Q51.5 Agenesis and aplasia of cervix	0.002	0.998	0.000
Q51.4 Unicornate uterus	0.002	0.998	0.000
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.002	0.998	0.000
Q51.0 Agenesis and aplasia of uterus	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
Q52.9 Congenital malformation of female genitalia, unspecified	0.002	0.998	0.000
Q52.8 Other specified congenital malformations of female genitalia	0.002	0.998	0.000
Q52.7 Other congenital malformations of vulva	0.002	0.998	0.000
Q52.6 Congenital malformation of clitoris	0.002	0.998	0.000
Q52.5 Fusion of labia	0.002	0.998	0.000
Q52.4 Other congenital malformations of vagina	0.002	0.998	0.000
Q52.3 Imperforate hymen	0.002	0.998	0.000
Q52.2 Congenital rectovaginal fistula	0.002	0.998	0.000
Q52.1 Doubling of vagina	0.002	0.998	0.000
Q52.0 Congenital absence of vagina	0.002	0.998	0.000
Q56.4 Indeterminate sex, unspecified	0.002	0.998	0.000
Q56.3 Pseudohermaphroditism, unspecified	0.002	0.998	0.000
Q56.2 Female pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.1 Male pseudohermaphroditism, not elsewhere classified	0.002	0.998	0.000
Q56.0 Hermaphroditism, not elsewhere classified	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.002	0.998	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.000	0.998	0.002
G51.0 Bell's palsy	0.002	0.998	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.998	0.002
S89.9 Unspecified injury of lower leg	0.000	0.998	0.002
K55 Vascular disorders of intestine	0.000	0.998	0.002
J98.0 Diseases of bronchus, not elsewhere classified	0.000	0.998	0.002
M50 Cervical disk disorders	0.000	0.998	0.002
G73.7 Myopathy other diseases classified elsewhere	0.002	0.998	0.000
G73.6 Myopathy in metabolic diseases	0.002	0.998	0.000
G73.5 Myopathy in endocrine diseases	0.002	0.998	0.000
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G73.3 Myasthenic syndromes in other diseases classified elsewhere	0.002	0.998	0.000
G73.2 Other myasthenic syndromes in neoplastic disease	0.002	0.998	0.000
G73.1 Eaton-Lambert syndrome	0.002	0.998	0.000
G73.0 Myasthenic syndromes in endocrine diseases	0.002	0.998	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.002	0.998	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.000	0.998	0.002
M34.0 Progressive systemic sclerosis	0.000	0.998	0.002
M50.3 Other cervical disk degeneration	0.000	0.998	0.002
Q51.3 Bicornate uterus	0.002	0.998	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.002	0.998	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.998	0.002
D12.3 Transverse colon	0.000	0.998	0.002
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.998	0.002
T51.9 Alcohol, unspecified	0.000	0.998	0.002
J91 Pleural effusion in conditions classified elsewhere	0.000	0.998	0.002
F60.8 Other specific personality disorders	0.000	0.998	0.002
F60.7 Dependent personality disorder	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.000	0.998	0.002
F60.4 Histrionic personality disorder	0.000	0.998	0.002
F60.2 Dissocial personality disorder	0.000	0.998	0.002
F60.1 Schizoid personality disorder	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
H27.1 Dislocation of lens	0.002	0.998	0.000
S29.9 Unspecified injury of thorax	0.002	0.998	0.000
Y60.0 During surgical operation	0.002	0.998	0.000
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
M79.0 Rheumatism, unspecified	0.000	0.998	0.002
Q51.8 Other congenital malformations of uterus and cervix	0.001	0.998	0.000
Y60.4 During endoscopic examination	0.002	0.998	0.000
D39.1 Ovary	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
K55.8 Other vascular disorders of intestine	0.000	0.998	0.002
N03 Chronic nephritic syndrome	0.002	0.998	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.000	0.998	0.002
M19.96 Arthrosis, unspecified-Lower leg	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
S92.41 Fracture of great toe (open)	0.002	0.998	0.000
L65.9 Nonscarring hair loss, unspecified	0.002	0.998	0.000
D40.1 Testis	0.002	0.998	0.000
D48.1 Connective and other soft tissue	0.002	0.998	0.000
K55.1 Chronic vascular disorders of intestine	0.000	0.998	0.001
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.000	0.998	0.001
C69.9 Eye, unspecified	0.002	0.998	0.000
R44.1 Visual hallucinations	0.002	0.998	0.000
K55.0 Acute vascular disorders of intestine	0.000	0.998	0.002
M50.2 Other cervical disk displacement	0.000	0.998	0.002
C71.3 Parietal lobe	0.002	0.998	0.000
D47.2 Monoclonal gammopathy	0.001	0.998	0.000
M50.8 Other cervical disk disorders	0.000	0.998	0.001
M96.8 Other postprocedural musculoskeletal disorders	0.000	0.998	0.002
S81.9 Open wound of lower leg, part unspecified	0.002	0.998	0.000
J93 Pneumothorax	0.000	0.998	0.002
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.001	0.998	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.002	0.998	0.000
G93.8 Other specified disorders of brain	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.001	0.998	0.000
Q21.0 Ventricular septal defect	0.001	0.998	0.000
Q24.8 Other specified congenital malformations of heart	0.001	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.998	0.001
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.998	0.001
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.998	0.001
M79.04 Rheumatism, unspecified (Hand)	0.000	0.998	0.001
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.998	0.001
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.998	0.001
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.998	0.001
N25.8 Other disorders resulting from impaired renal tubular function	0.001	0.998	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.998	0.000
Q21.8 Other congenital malformations of cardiac septa	0.001	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.001	0.998	0.000
Q21.3 Tetralogy of Fallot	0.001	0.998	0.000
Q21.2 Atrioventricular septal defect	0.001	0.998	0.000
C32.0 Glottis	0.000	0.999	0.001
D38.5 Other respiratory organs	0.001	0.999	0.000
K11.5 Sialolithiasis	0.000	0.999	0.001
L81.9 Disorder of pigmentation, unspecified	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
C71.4 Occipital lobe	0.001	0.999	0.000
N03.8 Other	0.001	0.999	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.001	0.999	0.000
N03.6 Dense deposit disease	0.001	0.999	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.001	0.999	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.999	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.999	0.000
N03.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
N03.1 Focal and segmental glomerular lesions	0.001	0.999	0.000
N03.0 Minor glomerular abnormality	0.001	0.999	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.000	0.999	0.001
O34.6 Maternal care for abnormality of vagina	0.000	0.999	0.001
O34.5 Maternal care for other abnormalities of gravid uterus	0.000	0.999	0.001
O34.4 Maternal care for other abnormalities of cervix	0.000	0.999	0.001
O34.0 Maternal care for congenital malformation of uterus	0.000	0.999	0.001
N08.3 Glomerular disorders in diabetes mellitus	0.001	0.999	0.000
S72.4 Fracture of lower end of femur	0.001	0.999	0.000
M79.08 Rheumatism, unspecified (Other)	0.000	0.999	0.001
C69.6 Orbit	0.001	0.999	0.000
C71.0 Cerebrum, except lobes and ventricles	0.001	0.999	0.000
I74.8 Embolism and thrombosis of other arteries	0.001	0.999	0.000
J93.0 Spontaneous tension pneumothorax	0.000	0.999	0.001
J99.8 Respiratory disorders in other diseases classified elsewhere	0.000	0.999	0.001
C69 Malignant neoplasm of eye and adnexa	0.001	0.999	0.000
I70 Atherosclerosis	0.001	0.999	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.001	0.999	0.000
I70.10 Atherosclerosis of renal artery (without gangrene)	0.001	0.999	0.000
S72.20 Subtrochanteric fracture (closed)	0.001	0.999	0.000
S72.41 Fracture of lower end of femur (open)	0.001	0.999	0.000
I70.1 Atherosclerosis of renal artery	0.001	0.999	0.000
N05.1 Focal and segmental glomerular lesions	0.001	0.999	0.000
O04.9 Complete or unspecified, without complication	0.001	0.999	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.000	0.999	0.001
Q27.3 Peripheral arteriovenous malformation	0.001	0.999	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
M50.9 Cervical disk disorder, unspecified	0.000	0.999	0.001
C71.7 Brain stem	0.001	0.999	0.000
C71.6 Cerebellum	0.001	0.999	0.000
C71.5 Cerebral ventricle	0.001	0.999	0.000
I67.8 Other specified cerebrovascular diseases	0.001	0.999	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.001	0.999	0.000
N05.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.001	0.999	0.000
G35 Multiple sclerosis	0.000	0.999	0.001
N05 Unspecified nephritic syndrome	0.001	0.999	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.001	0.999	0.000
I70.9 Generalised and unspecified atherosclerosis	0.001	0.999	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.001	0.999	0.000
I72 Other aneurysm	0.001	0.999	0.000
D11.0 Parotid gland	0.000	0.999	0.001
I70.8 Atherosclerosis of other arteries	0.001	0.999	0.000
I72.0 Aneurysm of carotid artery	0.001	0.999	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.001	0.999	0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.001	0.999	0.000
C69.8 Overlapping lesion of eye and adnexa	0.001	0.999	0.000
C69.5 Lachrymal gland and duct	0.001	0.999	0.000
C69.4 Ciliary body	0.001	0.999	0.000
C69.2 Retina	0.001	0.999	0.000
C69.1 Cornea	0.001	0.999	0.000
C69.0 Conjunctiva	0.001	0.999	0.000
G51.9 Disorder of facial nerve, unspecified	0.001	0.999	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.999	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations